Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: A new member of the viroporin family?

FEBS Letters

Volumn 584, Issue 10, 2010, Pages 2070-2075

  Silic Benussi, Micol ^a   Marin, Oriano ^a   Biasiotto, Roberta ^a   D'Agostino, Donna M ^a,b   Ciminale, Vincenzo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Apoptosis; Calcium homeostasis; HTLV 1; Leukemia; Mitochondria; Potassium channel; Viroporin

Indexed keywords

PROTEIN P13; UNCLASSIFIED DRUG; VIRAL CHANNEL PROTEIN; VIROPORIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; CELL CYCLE REGULATION; CELL ISOLATION; CELL METABOLISM; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; HUMAN T CELL LEUKEMIA VIRUS 1; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PERMEABILITY; POTASSIUM; RETROVIRIDAE PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77952673390     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.02.030     Document Type: Review

References (53)

1. Saggioro D., Silic-Benussi M., Biasiotto R., D'Agostino D.M., Ciminale V. Control of cell death pathways by HTLV-1 proteins. Front. Biosci. 2009, 14:3338-3351.
2. Nicot C., Harrod R.L., Ciminale V., Franchini G. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene 2005, 24:6026-6034.
3. D'Agostino D.M., Bernardi P., Chieco-Bianchi L., Ciminale V. Mitochondria as functional targets of proteins coded by human tumor viruses. Adv. Cancer Res. 2005, 94:87-142.
4. D'Agostino D.M., Ciminale V., Pavlakis G.N., Chieco-Bianchi L. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res. Hum. Retroviruses 1995, 11:1063-1071.
5. Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., Bairoch A. ProteiN IDENTIFICATION AND ANALYSIS TOOLS On the ExPASy Server. The Proteomics Protocols Handbook 2005, Humana Press, pp. 571-607.
6. D'Agostino D.M., et al. Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J. Biol. Chem. 2002, 277:34424-34433.
7. Ciminale V., Zotti L., D'Agostino D.M., Ferro T., Casareto L., Franchini G., Bernardi P., Chieco-Bianchi L. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene 1999, 18:4505-4514.
8. Scherf T., Kasher R., Balass M., Fridkin M., Fuchs S., Katchalski-Katzir E. A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity. Proc. Natl. Acad. Sci. USA 2001, 98:6629-6634.
9. Koralnik I.J., Fullen J., Franchini G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 1993, 67:2360-2366.
10. Ghorbel S., Sinha-Datta U., Dundr M., Brown M., Franchini G., Nicot C. Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J. Biol. Chem. 2006, 281:37150-37158.
11. Silic-Benussi M., et al. Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. Biochim. Biophys. Acta 2009, 1787:947-954.
12. Fontaine E., Eriksson O., Ichas F., Bernardi P. Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex i. J. Biol. Chem. 1998, 273:12662-12668.
13. Szewczyk A., Jarmuszkiewicz W., Kunz W.S. Mitochondrial potassium channels. IUBMB Life 2009, 61:134-143.
14. Hou X., Foley S., Cueto M., Robinson M.A. The human T-cell leukemia virus type I (HTLV-I) X region encoded protein p13(II) interacts with cellular proteins. Virology 2000, 277:127-135.
15. Lefebvre L., Ciminale V., Vanderplasschen A., D'Agostino D., Burny A., Willems L., Kettmann R. Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J. Virol. 2002, 76:7843-7854.
16. Gonzalez M.E., Carrasco L. Viroporins. FEBS Lett. 2003, 552:28-34.
17. Hiraragi H., Michael B., Nair A., Silic-Benussi M., Ciminale V., Lairmore M. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis. J. Virol. 2005, 79:9449-9457.
18. Silic-Benussi M., et al. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl. Acad. Sci. USA 2004, 101:6629-6634.
19. Giacomello M., Drago I., Pizzo P., Pozzan T. Mitochondrial Ca2+ as a key regulator of cell life and death. Cell Death Differ. 2007, 14:1267-1274.
20. Ardehali H., O'Rourke B. Mitochondrial K(ATP) channels in cell survival and death. J. Mol. Cell. Cardiol. 2005, 39:7-16.
21. Akao M., O'Rourke B., Kusuoka H., Teshima Y., Jones S.P., Marban E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ. Res. 2003, 92:195-202.
22. O'Brien V. Viruses and apoptosis. J. Gen. Virol. 1998, 79(Pt 8):1833-1845.
23. Agol V.I., et al. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect. Virology 1998, 252:343-353.
24. Carthy C.M., Granville D.J., Watson K.A., Anderson D.R., Wilson J.E., Yang D., Hunt D.W., McManus B.M. Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J. Virol. 1998, 72:7669-7675.
25. Grandgirard D., Studer E., Monney L., Belser T., Fellay I., Borner C., Michel M.R. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 1998, 17:1268-1278.
26. An S., Chen C.J., Yu X., Leibowitz J.L., Makino S. Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J. Virol. 1999, 73:7853-7859.
27. Kalkeri G., Khalap N., Garry R.F., Fermin C.D., Dash S. Hepatitis C virus protein expression induces apoptosis in HepG2 cells. Virology 2001, 282:26-37.
28. Wurzer W.J., Planz O., Ehrhardt C., Giner M., Silberzahn T., Pleschka S., Ludwig S. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 2003, 22:2717-2728.
29. Chen W., et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 2001, 7:1306-1312.
30. Lowy R.J. Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms. Int. Rev. Immunol. 2003, 22:425-449.
31. Zamarin D., Garcia-Sastre A., Xiao X., Wang R., Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 2005, 1:e4.
32. Coleman J.R. The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol. J. 2007, 4:9.
33. Zamarin D., Ortigoza M.B., Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 2006, 80:7976-7983.
34. Conenello G.M., Palese P. Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe 2007, 2:207-209.
35. Conenello G.M., Zamarin D., Perrone L.A., Tumpey T., Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007, 3:1414-1421.
36. McAuley J.L., Hornung F., Boyd K.L., Smith A.M., McKeon R., Bennink J., Yewdell J.W., McCullers J.A. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007, 2:240-249.
37. Mitzner D., et al. Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell. Microbiol. 2009, 11:1502-1516.
38. Nieva J.L., Agirre A., Nir S., Carrasco L. Mechanisms of membrane permeabilization by picornavirus 2B viroporin. FEBS Lett. 2003, 552:68-73.
39. van Kuppeveld F.J., van den Hurk P.J., Zoll J., Galama J.M., Melchers W.J. Mutagenesis of the coxsackie B3 virus 2B/2C cleavage site: determinants of processing efficiency and effects on viral replication. J. Virol. 1996, 70:7632-7640.
40. Madan V., Sanchez-Martinez S., Carrasco L., Nieva J.L. A peptide based on the pore-forming domain of pro-apoptotic poliovirus 2B viroporin targets mitochondria. Biochim. Biophys. Acta 2010, 1798:52-58.
41. Boya P., Pauleau A.L., Poncet D., Gonzalez-Polo R.A., Zamzami N., Kroemer G. Viral proteins targeting mitochondria: controlling cell death. Biochim. Biophys. Acta 2004, 1659:178-189.
42. Morellet N., Bouaziz S., Petitjean P., Roques B.P. NMR structure of the HIV-1 regulatory protein VPR. J. Mol. Biol. 2003, 327:215-227.
43. Jacotot E., et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 2000, 191:33-46.
44. Jain C., Belasco J.G. Structural model for the cooperative assembly of HIV-1 Rev multimers on the RRE as deduced from analysis of assembly-defective mutants. Mol. Cell 2001, 7:603-614.
45. Gallay P., Stitt V., Mundy C., Oettinger M., Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 1996, 70:1027-1032.
46. Yamashita M., Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog. 2005, 1:e18.
47. Bartz S.R., Rogel M.E., Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 1996, 70:2324-2331.
48. Goh W.C., Rogel M.E., Kinsey C.M., Michael S.F., Fultz P.N., Nowak M.A., Hahn B.H., Emerman M. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 1998, 4:65-71.
49. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995, 69:6705-6711.
50. Poon B., Grovit-Ferbas K., Stewart S.A., Chen I.S. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 1998, 281:266-269.
51. Stewart S.A., Poon B., Jowett J.B., Xie Y., Chen I.S. Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. Proc. Natl. Acad. Sci. USA 1999, 96:12039-12043.
52. Pang S., et al. Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr. Clin. Cancer Res. 2001, 7:3567-3573.
53. Liu Z., Sekito T., Spirek M., Thornton J., Butow R.A. Retrograde signaling is regulated by the dynamic interaction between Rtg2p and Mks1p. Mol. Cell 2003, 12:401-411.